New Zealand - engelsk - Medsafe (Medicines Safety Authority)

multichem nz limited - doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg - tablet - 4 mg - active: doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg - tablet - 4 mg - active: doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg excipient: lactose magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

clinect nz pty limited - doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin;   - tablet - 2 mg - active: doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

clinect nz pty limited - doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin;   - tablet - 4 mg - active: doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

apotex nz ltd - doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin;   - tablet - 1 mg - active: doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

USA - engelsk - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - doxazosin mesylate (unii: 86p6pqk0mu) (doxazosin - unii:nw1291f1w8) - doxazosin 1 mg - doxazosin tablets are indicated for the treatment of the signs and symptoms of bph. doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerou

Canada - engelsk - Health Canada

jamp pharma corporation - doxazosin (doxazosin mesylate) - tablet - 1mg - doxazosin (doxazosin mesylate) 1mg - alpha-adrenergic blocking agents

Canada - engelsk - Health Canada

jamp pharma corporation - doxazosin (doxazosin mesylate) - tablet - 2mg - doxazosin (doxazosin mesylate) 2mg - alpha-adrenergic blocking agents

Canada - engelsk - Health Canada

jamp pharma corporation - doxazosin (doxazosin mesylate) - tablet - 4mg - doxazosin (doxazosin mesylate) 4mg - alpha-adrenergic blocking agents

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios aurobindo, s.l.u. - doxazosina mesilato - comprimido - 4 mg - doxazosina mesilato 4 mg - doxazosina